Should we reconsider iron administration based on prevailing ferritin and hepcidin concentrations?

The results of recent randomized, controlled trials in patients with chronic kidney disease and anemia have suggested that hyporesponsiveness to erythropoiesis stimulating agents (ESA) is a significant predictor of poor patient outcomes. Functional iron deficiency (FID) is the most common cause of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakanishi, Takeshi, Kuragano, Takahiro, Kaibe, Shoji, Nagasawa, Yasuyuki, Hasuike, Yukiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521641/
https://www.ncbi.nlm.nih.gov/pubmed/23053592
http://dx.doi.org/10.1007/s10157-012-0694-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3521641/
https://www.ncbi.nlm.nih.gov/pubmed/23053592
http://dx.doi.org/10.1007/s10157-012-0694-3

Ejemplares similares